Condition
Tumors of the Central Nervous System
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Withdrawn1
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03332030Withdrawn
Stem Cells in NF1 Patients With Tumors of the Central Nervous System
NCT05641636CompletedPrimary
Cardiovascular Disorders and Risk Factors in Childhood Cranial and Craniospinal Tumors Survivors
NCT00633958Phase 1TerminatedPrimary
A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors
Showing all 3 trials